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1. Introduction 
Rhinitis is an inflammation of the mucosal lining of the nose and is characterized by one or 
more of the following symptoms: nasal congestion, anterior and posterior rhinorrhea, 
sneezing, and itching (Bousquet, Khaltaev et al. 2008; Wallace, Dykewicz et al. 2008). It can 
be associated with eye symptoms (rhinoconjuntivitis) and ear or throat complains 
(Bousquet, Khaltaev et al. 2008). Rhinitis can be classified etiologically in two types: Allergic 
Rhinitis (AR) and Nonallergic Rhinitis (Table1) (Bousquet, Khaltaev et al. 2008; Wallace, 
Dykewicz et al. 2008). 
The most common type is AR, and its prevalence has increased over the last decades 
(Bousquet, Khaltaev et al. 2008). Associated risk factors, such as atopy, family history of 
allergy, and exposure to allergens and pollution, might explain this fact (Bousquet, Khaltaev 
et al. 2008; Scadding, Durham et al. 2008). AR is a multifactorial disease influenced by 
genetic and environmental interaction (Davila, Mullol et al. 2009). Despite that 30-50% of 
rhinitis patients have non-allergic triggers, 44 to 87% might have a combination of allergic 
and non-allergic rhinitis mechanism (Dykewicz and Hamilos 2010). 
Allergic inflammation is the basic mechanism of this disease, and classically is considered to 
result from an IgE mediated reaction (Bousquet, Khaltaev et al. 2008). Allergic response can 
be biphasic, mediated by an early and a late phase (Durham 1998). Early phase response, 
occurs within the first 0-60 min following allergen exposure, and is mediated by mast cell 
degranulation and mediator release (Durham 1998; Bousquet, Khaltaev et al. 2008; Scadding, 
Durham et al. 2008). The late phase reaction involves inflammation, mediated by 
recruitment of several inflammatory cells, specifically Th2 mediated cell response (Durham 
1998). Clinically, AR appears as nasal sneezing, itching of the nose, rhinorrhoea and nasal 
blockage, in the first minutes after allergen contact. Symptoms like chronic obstruction, 
hyposmia, post-nasal mucous discharge and nasal hyper-reactivity occur in the late-phase 
response (Scadding, Durham et al. 2008; Lim and Leong 2010). 
World Health Organization (WHO) through the working group Allergic Rhinitis Impact on 
Asthma (ARIA), changed the classification from time of exposure point of view (seasonal, 
perennial and occupational) to a symptomatic definition (intermittent allergic rhinitis and 
persistent allergic rhinitis) and severity characterization (mild or moderate-severe). The seasonal 
and perennial rhinitis classification is still useful for diagnosis and immunotherapy 
treatment decision and can be used alongside with ARIA classification (Bousquet, Khaltaev 
et al. 2008). 
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I- Allergic rhinitis 
II- Nonallergic rhinitis 
A.Vasomotor rhinitis (triggered by irritant, cold air, exercise, undeterminated trigger) 
B. Gustatory rhinitis 
C. Infectious rhinitis 
III- Occupational rhinitis 
A. IgE mediated (protein or chemical allergens) 
B. Uncertain immune mechanism (chemical respiratory sensitizers) 
C. Work agravated rhinitis 
IV- Rhinitis syndromes 
A. Hormonal induced (pregnancy or menstrual cicle induced) 
B. Drug induced 
1. Rhinitis medicamentosa 
2. Nonsteroidal anti-inflammatory drugs 
3. Oral contraceptives 
4. Antihypertensive and cardiovascular agents 
C. Atrophic rhinitis 
D. Rhinitis associated with inflammatory-immunologic disorders 
1. Granulomatous infection 
2. Wegener granulomatous 
3. Sarcoidosis 
4. Midline granuloma 
5. Churgh-Strauss syndrome 
6. Relapsing polychondritis 
7. Amyloidosis 
Table 1. Rhinitis classification (adapted from Dykewicz and Hamilos 2010) 
The most frequent allergic triggers are inhalant allergens, namely mites, pollens, animals 
and fungi. According to different triggers they can cause perennial or seasonal symptoms. 
Pre-existing rhinitis can be aggravated by work-place irritants like smoke, cold air and 
pollutants (Scadding, Durham et al. 2008).  
Rhinitis has debilitating consequences, significantly interfering with patients quality of life 
and activity, namely in sports practice (Katelaris, Carrozzi et al. 2003). It has negative impact 
on cognitive functions, school performance, sleep, quality of life and even in behaviour, 
which can significantly impair athletics performance (Katelaris, Carrozzi et al. 2003). This is 
particularly important, as a higher prevalence of rhinitis has been reported in athletes than 
general population (Delgado, Moreira et al. 2006). Excluding exercise-induced rhinitis, 
idiopathic rhinitis and nasal symptoms related to physical, cold air, and chemical contact 
factors, allergic rhinitis can account for prevalences up to 30% in an athlete population. This 
chapter deals with allergic rhinitis in sports. 
2. Allergic rhinitis in athletes 
Exercise induces modulation in innate and adaptive immune system, dependent on host 
defence, activity level and disease susceptibility (Walsh, Gleeson et al. 2011). This might 
explain why in some cases there seems to be a possible susceptibility of elite athletes to 
infection, namely in the upper respiratory tract infection (Moreira 2009; Dijkstra and 
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Robson-Ansley 2011). In a recent position statement regarding immune function and 
exercise, Walsh and colleagues (Walsh, Gleeson et al. 2011) proposed that in young healthy 
subjects, who already possess excellent immune responses, an increase in physical activity 
might not be beneficial to the immune system response, and might induce immune-disease 
susceptibility, like auto-immune disease or allergy. In fact, self-reported episodes of 
infection may not be related with infection per se, but with allergy-related symptoms 
(Dijkstra and Robson-Ansley 2011). On other side, the positive effects of exercise training on 
immune function are more frequently seen when immune function is sub-optimal like in 
elderly people (Walsh, Gleeson et al. 2011). 
There is also immunological data that exercise training can lead to a polarization of T-helper 
lymphocytes toward the Th2 phenotype, which is known to mediate allergic response 
(Dijkstra and Robson-Ansley 2011). Athletes and people who regularly exercise in the 
outdoor urban environment are a specific population in risk for allergic rhinitis (Delgado, 
Moreira et al. 2006). There is evidence indicating an increased incidence of exercise-induce 
bronchospasm and atopy in highly trained athletes compared with nonathletic controls 
(Carlsen, Anderson et al. 2008). 
2.1 Nasal physiology and pathophysiology 
The upper airways, that include nasal cavity and its tissues, lie in a bony structure that, 
unlike the lower airways structure, cannot change shape (Dahl and Mygind 1998). Upper 
airways comprise an epithelium with a basement membrane and a submucosal layer, which 
is full of venous sinusoids (Dahl and Mygind 1998). These vessels and mucosa glands are 
responsible for filtration, humidification and warming of inhaled air before it reaches the 
lower respiratory tract. They are regulated by autonomic nervous system reflexes (Delgado, 
Moreira et al. 2006) and swelling of the venous sinusoids can lead to upper airway 
obstruction (Dahl and Mygind 1998). Activation of local nerve reflexes causes sneezing, 
watery discharge and vasodilation, symptoms associated with rhinitis(Dahl and Mygind 
1998). 
During exercise, autonomic reflexes improve nasal efficiency (Bonini, Bonini et al. 2006). In 
dynamic exercise training due to an increase of nasal sympathetic activity, venous sinusoids 
constrict. The same does not happen with isometric exercise types (Dahl and Mygind 1998; 
Bonini, Bonini et al. 2006). A watery discharge can also be produced, because cold air 
induces glandular hyper secretion (Dahl and Mygind 1998; Bonini, Bonini et al. 2006). 
During training athletes are repeatedly exposed to several risk factors (allergens, cold air 
and pollutants) increasing rhinitis symptoms in susceptible individuals (Delgado, Moreira et 
al. 2006). Some experience improvement with exercise, mediated by nasal sympathetic tone, 
others may have their symptoms worsen (Valero, Serrano et al. 2005). In fact, weather 
conditions, like cold or dry air, inhalation of irritants in outdoor exercise exposure can 
explain the worsening symptoms in some athletes (Schwartz, Delgado et al. 2008). In 
swimmers chlorine inhalation (an irritant) induces nasal congestion in a more pronounced 
way in subjects with allergic rhinitis than in nonrhinitic. Some authors explained this fact by 
nasal mucosa damage mediated by chlorinated products, which could facilitate the 
penetration of aeroallergens increasing the risk of allergic manifestation (Shusterman, 
Murphy et al. 1998; Shusterman, Balmes et al. 2003; Shusterman, Murphy et al. 2003). This 
hypothesis was not supported by a more recent study showing that swimmers had worse 
rhinitis symptoms, but independently of their atopic status (Alves, Martins et al. 2010).  
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2.2 Epidemiology 
Allergic rhinitis affects 10-20% of general population, and in a higher percentage elite 
competitive athletes (Katelaris, Carrozzi et al. 2006; Bousquet, Khaltaev et al. 2008). A study 
in 291 German athletes found a significative increased prevalence of hay fever (25% versus 
17% in general population), with the highest prevalence in endurance athletes (Thomas, 
Wolfarth et al. 2010). These data are concordant with previous data, namely a Canadian 
study of 698 athletes who practiced different sports under antagonist conditions (dry, cold, 
humid or mixed air conditions) - a 21% prevalence of allergic rhinitis was found in all 
participants, except in subjects training in dry air conditions (17%) (Langdeau, Turcotte et al. 
2004). In 162 Finish swimmers, 29% had a positive skin test reaction to pollen associated 
with rhinoconjunctivitis symptoms during spring or summer (Helenius and Haahtela 2000). 
During the 1990`s, several epidemiological studies of athletes in different sports were made 
using larger samples. Two studies with 2060 (Helbling, Jenoure et al. 1990) and 1530 Swiss 
athletes (Kaelin and Brandli 1993) showed a prevalence of rhinoconjunctivitis of respectively 
16,8 and 19,7%. In several studies published in the last two decades a prevalence range 
between 13.3-48.6% was found (Delgado, Moreira et al. 2006) Table 2. 
 
Reference Design and methods 
Year of study, subjects 
(n) 
Rhinitis/SARC* 
Prevalence (%) 
Fitch KD, J Allergy Clin 
Immunol 1984;73:72-7 
Retrospective; medical 
records analysis 
1976, Australian 
Olympics (185) 
8.6 
  
1980, Australian 
Olympics (106) 
7.5 
Helbling A, Schweiz 
Med Wochenschr 
1990;120(7):231-6 
Cross-sectional; 
questionnaire 
1986, Swiss athletes 
(2,060) 
16.8* 
Kaelin M, Schweiz Med 
Wochenschr 1993; 123(5): 
174-82 
Cross-sectional; 
questionnaire 
1990, Swiss athletes 
(1530) 
19.7%* 
Potts J, Sports Med 1996; 
21:256–261 
Cross-sectional; 
questionnaire 
1995, Canadian 
swimmers (738) 
19.0* 
Helenius I, J Allergy Clin 
Immunol 1998; 
101(5):646-52 
Cross-sectional; skin 
prick tests with 
medical diagnosis 
1996, Finnish summer 
athletes (162) 
29.6* 
Weiler J, J Allergy Clin 
Immunol 1998; 102:722-6
Cross-sectional, 
questionnaire  
(USOC-MHQ) 
1996, US summer 
Olympics (699) 
16.9 
Weiler J, J Allergy Clin 
Immunol 2000; 106:267-1
Cross-sectional, 
questionnaire  
(USOC-MHQ) 
1998, US winter 
Olympics (699) 
13.3 
Katelaris CH, J Allergy 
Clin Immunol 2000; 
106:260-6 
Cross-sectional; skin 
prick tests with 
medical diagnosis 
1997/8, Australian 
summer Olympics (214)
41.0/29.0* 
Katelaris CH, Clin J 
Sport Med 2006; 
16(5):401-5 
Cross-sectional; skin 
prick tests with 
medical diagnosis 
1999, Australian 
Olympics/Paralympics 
(977) 
37.0/24.0* 
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Lapucci G, J Allergy Clin 
Immunol 2003; 111:S142 
Cross-sectional; skin 
prick tests with 
medical diagnosis 
2000, Italian summer 
Olympics (265) 
25.3* 
Bonadonna P, Am J 
Rhinol. 2001; 15(5):297-
301. 
Cross-sectional, 
questionnaire on 
cold-induced rhinitis
2001, Italian skiers (144) 48.6 
Alaranta A, Med Sci 
Sports Exerc 2005 ; 37, 5, 
707–11 
Cross-sectional; self 
reported medical 
diagnosis 
2002, Finnish Olympic 
athletes (446); 
26.5 
  
Subgroup of endurance 
athletes (108) 
36.1 
Randolph C. Med Sci 
Sport Exerc 2006:2053–7 
Cross-sectional; 
questionnaire  
(USOC-MHQ) 
2003/4, US recreational 
runners (484) 
34.7 
Moreira A. Respir Med 
2007;101(6):1123–31 
Cross-sectional; self 
reported medical 
diagnosis 
2003, Finnish marathon 
runners (141) 
17.3 
Bonini M, Allergy 2007: 
62: 1166-70 
Cross-sectional; 
medical diagnosis 
2006, Italian 
preOlympics (98) 
34.7 
Macucci F, J Sports Med 
Phys Fitness. 2007 ; 
47(3):351-5 
Cross-sectional; 
medical diagnosis 
2006, Italian young 
athletes (352) 
22.2 
Salonen RO, Environ Int. 
2008; 34(1):51-7 
Cross-sectional; self 
reported medical 
diagnosis 
2007, Finnish young 
hockey players (793) 
18.3 
Thomas S; Allergy 
Asthma Clin Immunol. 
2010 Nov 30;6(1):31. 
Cross-sectional; 
questionnaire 
2008, German athletes 
candidates for Summer 
Olympic Games (291) 
25* 
Table 2. Prevalence (%) of rhinitis or seasonal allergic rhinoconjunctivitis (SARC) in athletes 
adapted and updated from Schwartz, Delgado et al. 2008.. 
Allergic rhinitis and asthma frequently co-exist and it seems to be a higher prevalence of 
asthma in athletes than in the general population (Thomas, Wolfarth et al. 2010). The 
prevalence of asthma in both the Summer and Winter Olympic athletes has been progressively 
increasing over recent years (Li, Lu et al. 2008). The prevalence of asthma reported in elite 
athletes ranged between 3.7-22.8% depending on athletes population (Bonini, Bonini et al. 
2006). An evidence-based review of Joint Task Force of the European Respiratory Society (ERS) 
and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with 
GA2LEN concluded that top athletes are at increased risk of asthma and bronchial 
hyperactivity, especially with endurance sports practice (Carlsen, Anderson et al. 2008). 
The allergic response causes nasal and conjunctival congestion, tearing, breathing 
difficulties, pruritus, fatigue, and mood changes, which might affect athletic performance 
(Komarow and Postolache 2005). Kateralis showed over spring season a negative effect of 
allergic rhinoconjuntivitis on performance scores (ability to train and compete). Also a 
resolution of those symptoms, namely eye symptoms, and improvement on quality of life 
and performance scores, was seen after treatment with intranasal corticosteroids (Katelaris, 
Carrozzi et al. 2002). 
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2.3 Risk factors and exposure 
During exercise ventilation increases in power athletes for a short period of time and for 
longer periods in resistance athletes (Bonini, Bonini et al. 2006). Most of this exercise is 
practiced in outdoor environments; therefore, athletes are strongly and repeatedly exposed 
to large amounts of aeroallergens and pollutants, including smoke. This contact in training 
or in competition periods may increase the likelihood of exercise-induced respiratory 
symptoms (Delgado, Moreira et al. 2006). The climate conditions, namely the inhaled air 
temperature and humidity also affect these patients. In swimmers it is also important to 
consider the contact with chlorine derivatives (Bonini, Bonini et al. 2006; Alves, Martins et 
al. 2010). 
2.3.1 Allergens 
Athletes involved in outdoor sports frequently exercise during or just after peak allergen 
seasons. In fact, major sports events frequently occur at the end of spring and beginning of 
the summer, and in urban settings (Delgado, Moreira et al. 2006). The Sydney Olympic 
Games were the second games in the last century to be held in springtime (Katelaris, 
Carrozzi et al. 2006). Kateralis monitored the pollen levels at Olympic Sydney facilities, and 
performed a study on Australian elite athletes in order to ascertain the prevalence of allergic 
conjunctivitis, sensitization and quality of life effect. They found that 41% had allergic 
rhinoconjunctivitis and, in those with pollen allergy (29%), a significant increase in nasal 
symptoms with a decreased quality of life score were found (Katelaris, Carrozzi et al. 2000). 
Aquatic sports athletes were more prone to be symptomatic. 
Aerobiological records of pollens are frequently used to monitor the pollen levels and it is 
important for athletes to prepare themselves, particularly if they are symptomatic to some 
allergen. An example was the set up of an aerobiological network for the Athens summer 
Olympic Games (Gioulekas, Damialis et al. 2003). 
Indoor allergens, namely mites, are not usually studied, due to the decreased frequency of 
contact and the specific association of more severe symptoms with endurance outdoor 
exercise. However, in some more indoor sports persistent rhinitis symptoms can occur and 
it may be relevant to control this environmental exposure in order to achieve the highest 
performance levels. 
2.3.2 Air pollution 
Urban type pollution, automobile and factory exhausts, tobacco smoking and occupational 
exposures are of great concern globally. Pollutants seem to interact with allergens in 
inducing sensitization and triggering symptoms in allergic patients (Bonini, Bonini et al. 
2006). Increased reactivity to irritants is a phenotypic characteristic of both allergic and non-
allergic rhinitis (Bousquet, Khaltaev et al. 2008). There are several studies pointing to 
adverse effects of outdoor air pollution, caused by carbon monoxide, nitric oxide and ozone 
among others (Delgado, Moreira et al. 2006). The two agents that most frequently affect 
upper respiratory airways and rhinitis are: particulate matter, namely diesel exhaust 
particles (DEP), which result from incomplete combustion of fuels and lubricants (Bousquet, 
Khaltaev et al. 2008) and volatile organic compounds, whose secondary pollutant is ozone 
formed through sun-light dependent reaction of volatile compounds. Their peak production 
is from April to September in the Northern Hemisphere, and a large percentage (40%) is 
completely absorbed by nasal mucosa (Bousquet, Khaltaev et al. 2008). They enhance the 
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production of oxygen’s derivatives, increasing the permeability of epithelial cells (Bonay 
and Aubier 2007). Ozone increases the late-phase response to nasal allergens, increasing the 
eosinophilic influx after exposure and, in nasal mucosa, the histamine containing and 
inflammatory cells are increased in number (Delgado, Moreira et al. 2006). 
In several studies it has been shown that patients living in traffic congested areas have more 
severe rhinitis and conjunctivitis symptoms (D'Amato and Cecchi 2008). A recently 
published study in Beijing, using questionnaires in 31,829 individuals and monitoring 
PM10, SO2 and NO2 air levels, found a significant association between outpatient visits for 
allergic rhinitis and increasing air pollutant levels (Zhang, Wang et al. 2011). DEP have pro-
allergic effects and, associated with pollen exposure, might induce an allergic breakthrough 
in atopic patients and increase allergic reactions in already symptomatic ones (Delgado, 
Moreira et al. 2006; Lubitz, Schober et al. 2010). This finding is particularly relevant in 
athletes who train or compete in outdoor urban environments. So, at the Olympic Games in 
China, besides allergen monitoring air quality was also monitored to certify air quality, in 
order athletes could perform their sports safely (Li, Lu et al. 2008). In fact, elite athletes 
practice sport around the world under different conditions and should be informed to what 
environment exposure they will be submitted, to adapt themselves and have appropriate 
preventive measures, namely their allergic symptoms fully controlled. 
Besides nasal symptoms, lower airway pathways can also be severely affected, with 
increasing bronchial hyperactivity and asthma (Bonay and Aubier 2007). 
Tobacco smoke is not advised in all populations, and especially in sports practice. Despite 
this, some athletes smoke or are exposed to passive smoke. Nasal symptoms, rhinorrea and 
nasal obstruction can occur under tobacco exposure, but not always these are consistent 
with increased total and specific IgEs (Bousquet, Khaltaev et al. 2008). 
2.3.3 Climate exposure 
The exposure to different environmental conditions, that are specific to a particular sport, 
definitely contribute to rhinitis symptoms. Rhinorhea and nasal congestion after exposure to 
cold air, known as “skier´s nose”, can occur in normal individuals, through parasympathetic 
reflex. This mechanism of rhinitis is not associated with a particular allergic aetiology. In 
fact, cold dry air is frequently used for determining the presence and degree of nasal 
hyperreactivity in nonallergic non-infectious perennial rhinitis (Braat, Mulder et al. 1998). In 
high performance athletes, namely skiers, long distance runners and swimmers with long 
term exposure to cold, the repeated cooling and drying of mucosa results in an 
inflammatory infiltration of the airway mucosa, and these effects are reversed after stopping 
the high performance exercise (Koskela 2007). 
In runners, an initial decongestion of mucosa occurs and it is maintained nearly 30 minutes 
after stopping exercise. This reduction of nasal resistance can lead to mucosa dehydration 
and a rebound increase in nasal secretion to compensate it. This “runner`s nose” is also 
integrated in differential diagnosis of allergic rhinitis (Bonini, Bonini et al. 2006). Swimmers 
are also a specific population of athletes. Their long term and high exposure to chlorine 
derivatives during regular trainings and competition at increased ventilation can induce 
mucosal inflammation which facilitate the responsiveness to airborne allergens and induces 
bronchial hyper responsiveness. Kateralis found confirming data in a group of swimmers 
that were more likely to have rhinitis symptoms and allergic sensitization than those active 
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in other sports (Katelaris, Carrozzi et al. 2000). In a recent study evaluating the nasal 
response to exercise in competitive swimmers compared with runners, although swimmers 
experienced worsening of nasal function after training, these data were independent of the 
atopic status of the athlete (Alves, Martins et al. 2010), which imposes the question of the 
swimmers environment as a risk factor for rhinitis. 
2.3.4 Infections 
Upper respiratory infections, namely acute viral rhinosinusitis, are extremely common in 
general population. It seems that athletes have an increased incidence, although a 
comprehensive explanation of this phenomenon was not yet found (Moreira 2009). A recent 
position statement questions the infectious aetiology of these respiratory symptoms, as few 
of them had no infectious agent identified. So these symptoms might be due only to an 
increased inflammation state (Walsh, Gleeson et al. 2011). 
2.4 Effects of allergic rhinitis on exercise performance 
Allergic rhinoconjunctivitis may be associated with a significant morbidity and a negative 
impact on life quality. In the general population, cognitive functions, school performance, 
sleep and even behavioural effects were described, namely in children with attention-deficit 
hyperreactivity disorders (Borres 2009). In a questionnaire of quality of life performed at 
spring-time, Kateralis showed poorer results in the allergic group, although the sample 
number was small (18 athletes) (Katelaris, Carrozzi et al. 2003). In another study with a 
larger sample, 145 athletes with allergic rhinitis who agreed to be treated, had a significant 
improvement of their quality of life scores under budesonide therapy (Katelaris, Carrozzi et 
al. 2002). Until now it was not possible to confirm the association of poorly treated rhinitis 
and a bad exercise performance (Dijkstra and Robson-Ansley 2011). It seems probable that 
altered airflow dynamics and ventilation caused by allergic rhinitis and nasal obstruction 
can potentially have a negative effect, mainly in high-intensity activities (Dijkstra and 
Robson-Ansley 2011). Any factors affecting sleep, decreasing the ability to concentrate or 
reducing physical fitness, have an easy understandable impact on sports performance. So, 
despite a direct association has not been proven yet, an indirect one is easily extrapolated 
(Dijkstra and Robson-Ansley 2011). 
The cognitive impact (learning ability and memory) of rhinitis has been particularly 
studied in children and it seems that patients on anti-histaminic therapy have worse 
outcomes than patients on placebo (Borres 2009). In a recent study, children with allergic 
rhinitis on second generation anti-histaminic drugs had a greater treatment satisfaction 
(Ferrer, Morais-Almeida et al. 2010). Learning disability is a consequence of the frequent 
sleep disturbances, resulting in daytime sleepiness. Impaired sleep is secondary to nasal 
congestion which causes micro-arousal and irregular breathing, with snoring and apnea. 
A secondary effect of all this is school and work absenteeism and training capacity 
disability (Borres 2009). Correct diagnosis and management of allergic rhinitis can reduce 
the disease impact. 
2.5 Diagnosis  
Diagnosis of allergic rhinitis in athletes is based in the concordance of a suggestive history of 
allergic symptoms and physical examination, supported by diagnostic tests. (Bousquet, 
Khaltaev et al. 2008; Scadding, Hellings et al. 2011). 
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2.5.1 History and physical examination 
A thorough allergic history remains the best diagnostic tool available (Wallace, Dykewicz et 
al. 2008; Scadding, Hellings et al. 2011). It is essential for an accurate diagnosis of rhinitis 
and for assessment of its severity and treatment response (Bousquet, Khaltaev et al. 2008). 
The patient, in this case the athlete, may present with a variety of symptoms and signs 
associated with allergic rhinitis such as sneezing, anterior rhinorrhoea and bilateral nasal 
obstruction (Dijkstra and Robson-Ansley 2011). Frequently, ocular symptoms are 
concomitant with tearing, burning and itching. Other symptoms include significant loss of 
smell (hyposmia or anosmia), snoring, post nasal drip or chronic cough, itching ears, nose 
and throat (Bousquet, Khaltaev et al. 2008; Dijkstra and Robson-Ansley 2011). In athletes, 
clinical presentation is frequently more subtle and might include poor-quality sleep, fatigue, 
reduced exercise performance and difficulty to recover after more demanding exercise 
sessions (Dijkstra and Robson-Ansley 2011). An effective evaluation should include 
symptoms characterization pattern, chronicity, seasonality and triggers of nasal and related 
symptoms, medications response, presence of coexisting conditions and the relation with 
training practice. It is also very important to include assessment of quality of life (Wallace, 
Dykewicz et al. 2008). 
Physical examination of all organ systems potentially affected by allergies should be 
performed. Further attention should be given for upper respiratory tract system, namely 
nasal and oropharyngeal examination. Usually in patients with mild intermittent allergic 
rhinitis, a nasal examination is normal. In other patients, the nasal examination can show 
bluish-grey discoloration and edema or erythema of mucosa with clear watery rhinorrhoea 
(Scadding, Hellings et al. 2011). Infectious complications of rhinitis to which athletes seem to 
be more prone, like otitis and sinusitis, should be discarded during this examination (Lim 
and Leong 2010). It is important to explore, during clinical investigations, the differential 
diagnosis for similar symptoms, like non-allergic ones.  
2.5.2 Investigations 
In an athlete with persistent symptoms or when an allergic aetiology for upper respiratory 
symptoms is suspected, skin prick testing (SPT) with standardized allergens and/or 
measurement of allergen-specific IgE in serum should be used. Further investigation of 
other allergic diseases, namely asthma or exercise-induced bronchospasm should be 
considered and studied accordingly (Carlsen, Anderson et al. 2008). 
 Skin prick tests are relevant markers of the IgE-mediated allergic reaction (Bousquet, 
Khaltaev et al. 2008; Scadding, Durham et al. 2008). They should be carried out in all cases of 
suspected allergic rhinitis (Scadding, Durham et al. 2008) because there is a high degree of 
correlation between symptoms and provocative challenges (Bousquet, Khaltaev et al. 2008). 
The skin reaction is, however, dependent on several variables, namely the quality of the 
allergen extracts, age, seasonal variation of the sensitization, medications, and even the test 
interpretation can vary between individuals (Bousquet, Khaltaev et al. 2008; Scadding, 
Hellings et al. 2011). False positives mostly occur due to dermographism or irritant 
substances and false negatives are secondary to poor potency extracts, suppressed skin 
reaction due to antihistamines, tricyclic antidepressants or topical steroids, or an improper 
technique (Bousquet, Khaltaev et al. 2008; Scadding, Durham et al. 2008). 
Using a radioimmunoassay or enzyme immunoassay it is possible to measure serum-total 
IgE and serum-specific IgE. These can be requested when skin tests are not possible, such as 
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patients under therapy suppressing skin reactivity or when SPT in association with the 
clinical exam are not concordant (Bousquet, Khaltaev et al. 2008; Scadding, Durham et al. 
2008; Wallace, Dykewicz et al. 2008). An isolated total IgE measurement alone should not be 
used for screening allergic diseases, but may aid the interpretation of specific IgE tests 
(Bousquet, Khaltaev et al. 2008; Scadding, Durham et al. 2008). The sensitivity of serum 
specific IgE measurements compared with SPT can vary with the immunoassay technique 
used (Wallace, Dykewicz et al. 2008). Other in vitro tests used are peripheral blood activation 
markers, through the evaluation of blood basophiles response of degranulation and 
mediators release (histamine, CysTL, CD63/ CD203c expression) after stimulation with 
specific allergens. These tests are still just used for investigation (Bousquet, Khaltaev et al. 
2008). 
Nasal challenge tests are not necessary to confirm diagnosis. They are usually used for 
research. (Bousquet, Khaltaev et al. 2008; Scadding, Durham et al. 2008) 
Imaging of the nose and sino-nasal cavity is used to differentiate the source of sino-nasal 
symptoms, relation of sino-nasal problem with surrounding structures and the extent of the 
disease (Scadding, Hellings et al. 2011). Plain sinus radiographs are not indicated in allergic 
rhinitis or rhinosinusitis diagnosis (Bousquet, Khaltaev et al. 2008). Computerized 
tomography scan is actually the main radiological investigation for sino-nasal disorders. It is 
indicated for differential diagnosis purposes, to exclude chronic rhinosinusitis, eliminate 
rhinitis complication and to evaluate non-responders to treatment (Bousquet, Khaltaev et al. 
2008; Scadding, Hellings et al. 2011). It can be particularly useful in athletes to exclude 
traumatic lesions, which occur frequently in close-contact sports, like box or soccer. It can 
also be used for monitoring allergic rhinitis disease complications. Magnetic resonance 
imaging is rarely indicated. 
2.5.3 Evaluation tests for severity and allergic rhinitis control 
To evaluate severity in an objective way measurements of nasal obstruction and smell are 
used (Bousquet, Khaltaev et al. 2008). These tests are not made in routine clinical practice 
but can be useful when allergen challenges are undertaken or septal surgery is contemplated 
(Scadding, Durham et al. 2008). 
Nasal patency can be monitored objectively using nasal peak inspiratory and expiratory 
flow, acoustic rhinometry, that measures the nasal cavity volume, and rhinomanometry that 
measures nasal airflow and pressure (Scadding, Hellings et al. 2011). In clinical practice the 
most frequently used is peak nasal inspiratory flow because it is simple, cheap, fast, 
available and it can be used for disease home monitoring (Wallace, Dykewicz et al. 2008). 
Olfactory tests are subjective test that measure odour threshold, discrimination and 
identification (Bousquet, Khaltaev et al. 2008; Scadding, Durham et al. 2008). 
Nasal nitric oxide measurement may be a useful tool in diagnosis, management and to alert 
for possible mucociliary defects, but its utility in allergic rhinitis needs to be further 
evaluated (Bousquet, Khaltaev et al. 2008; Scadding, Hellings et al. 2011). 
Rhinitis control is frequently monitored with control questionnaires and visual analogue 
scales (Bousquet, Khaltaev et al. 2008). There are several questionnaires, and some are being 
proposed for validation, but none is specific for the athletic population. The Rhinitis Control 
Assessment Test, a 6-item patient completed instrument, and Control of Allergic Rhinitis 
and Asthma Test (CARAT), which uses 10 questions, are such examples (Fonseca, Nogueira-
Silva et al. 2010; Schatz, Meltzer et al. 2010). Specific questionnaires for athletes are also 
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available, such the Allergy Questionnaire for Atheletes (AQUA) that was developed by 
Bonini, adapting the European Community Respiratory Health Survey Questionnaire 
(Bonini, Braido et al. 2009). 
2.6 Management allergic rhinitis in athletes 
Management of allergic rhinitis encompasses patient education, environmental control, 
pharmacotherapy and allergen-specific immunotherapy. Surgical options may be used in 
highly selected cases (Bousquet, Khaltaev et al. 2008). Appropriate management requires an 
“evidence-based medicine” approach, as it is recommended on 2008 and 2010 guidelines of 
Allergic Rhinitis and its Impact on Asthma (ARIA)(Bousquet, Khaltaev et al. 2008; Brozek, 
Bousquet et al. 2010). For the elite athlete, it is also important to minimise the potential 
detrimental effects of allergic symptoms and treatment on performance (Katelaris, Carrozzi 
et al. 2003). 
Treatment requires careful planning to comply to the “anti-doping” regulations and avoid 
detrimental influences of treatment adverse effects (Katelaris, Carrozzi et al. 2003). Specific 
aims for the athlete population are outlined in table 3. 
 
Management Plan 
Early recognition and diagnosis to avoid exposure to peak levels of relevant allergens and 
pollutants 
Reduction of symptoms and improvement of nasal function to minimize negative effects 
on sport performance and the risk of exercise-induced asthma 
Use therapies complying with World Anti-Doping Agency, not affecting athletic 
performance 
Table 3. Allergic rhinitis in athletes management plan adapted from (Delgado, Moreira et al. 
2006) 
2.6.1 Environmental control 
Reducing allergen exposure has proven to result in improving the severity of the disease 
and reducing the need for drugs (van Cauwenberge, Bachert et al. 2000). The beneficial 
effect may take weeks or months to be fully perceived (van Cauwenberge, Bachert et al. 
2000). In most cases, and specifically in athletes, complete avoidance is unfeasible (Moreira, 
Kekkonen et al. 2007). Nevertheless, measures aiming to reduce relevant allergens should be 
promoted, and are considered as a first step in management. As far as house-dust-mites are 
concerned, there are some measures like removing carpets from the bedroom, careful and 
daily cleaning, and regular change of bed linen. Another inhalant allergen, quite important 
for athletes seasonal activity, are pollens. For athletes it is often impossible to avoid this 
stimuli due to its ubiquitous presence, but following pollen forecasts and adapting training 
venues, time of day and training using appropriate face equipment may minimize exposure, 
at least to peak pollen levels (Wallace, Dykewicz et al. 2008; Dijkstra and Robson-Ansley 
2011). Irritants reported to cause nasal symptoms include tobacco smoke, pollution, chlorine 
and cold air (Wallace, Dykewicz et al. 2008). To prevent high level exposure to these agents 
some control of the training environment can be achieved improving ventilation systems of 
swimming pools and ice arenas (Delgado, Moreira et al. 2006) and taking measures to 
reduce global pollution, such as the one taken in the Chinese Olympic Games (Zhang, Wang 
et al. 2011). Allergic athletes should avoid outdoor training during pollen, ozone or air 
pollution alert periods. 
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2.6.2 Pharmacologic therapy of rhinitis in athletes 
The selection of treatment for a patient depends on multiple factors: type of rhinitis, 
symptom severity, patient age and job (Wallace, Dykewicz et al. 2008). There is limited 
medical-evidence to what treatment options should be used in elite athletes. Management of 
allergic rhinitis should be adapted to accommodate factors that may hazard the athlete 
performance, and the balance between efficacy and safety should be addressed before 
prescribing. In elite athletes the drug must be accepted by the World Anti-Doping Agency 
(WADA) rules. 
2.6.2.1 H1 anti-histamines 
H-1 receptor antagonists or H1 anti-histamines are drugs that block histamine at H1-
receptor level (neutral antagonists or inverse agonists). They are effective in symptoms 
mediated by histamine, namely rhinorrhoea, sneezing, nasal and eye itching (Bousquet, 
Khaltaev et al. 2008). The recommended treatment in the most updated guidelines for 
allergic rhinitis patients is the second-generation oral H1-anti-histamines (e.g. rupatadine, 
ebastine, azelastine, levocetirizine or desloratadine), that do not have anti-cholinergic and 
sedative, cognitive and psychomotor effects (Brozek, Bousquet et al. 2010). Athletes benefit 
the most with these choices, namely endurance athletes, since first generation H1 anti-
histamines may reduce psychomotor skills by their sedative effect and, by their 
anticholinergic activity, cause mucosal drying and reduce sweating and temperature 
regulation (Delgado, Moreira et al. 2006; Dijkstra and Robson-Ansley 2011). Some authors 
even propose a cautious approach in the prescription of any anti-histamines 24-48h before a 
major competition (Dijkstra and Robson-Ansley 2011). 
Intranasal H1-antihistamine (azelastine and levocabastine) are locally effective reducing 
itching, sneezing, runny nose and nasal congestion (Bousquet, Khaltaev et al. 2008). Due to 
their rapid and topical effects they can be used on demand by athletes to treat acute 
unexplained symptoms in the sport field (Delgado, Moreira et al. 2006). Ocular medication 
with anti-histamine compounds, using for example olopatadine (with a dual effect of mast 
cell stabilization), is quite effective in eye symptoms (van Cauwenberge, Bachert et al. 2000) 
2.6.2.2 Decongestants 
Decongestants, as vasoconstrictor drugs, act on the adrenergic receptor reducing nasal 
obstruction. Their side effects (increased blood pressure, heart rate, central nervous system 
stimulation) limit their use (van Cauwenberge, Bachert et al. 2000). Their clinical use should be 
limited to a short-term (<5 days) in order to avoid rhinitis medicamentosa and should not be 
used isolated (Brozek, Bousquet et al. 2010). Oral use should be carefully considered or 
avoided in the elite athletes because some of them are forbidden by WADA 2011. For example 
ephedrine and methylephedrine are prohibited when its concentration in urine is greater than 
10 micrograms per milliliter, and pseudoephedrine when its urine concentration is greater 
than 150 micrograms per milliliter; doses under 150 micrograms per milliliter in urine are now 
being monitored in order to detect patterns of misuse (WADA 2011). 
2.6.2.3 Corticosteroids 
Intranasal glucocorticosteroids are the most efficacious medication available for allergic and 
non-allergic rhinitis treatment (Bousquet, Khaltaev et al. 2008; Scadding, Durham et al. 2008). 
These medications are safe to be used in athletes and effective in all symptoms of allergic 
rhinitis as well as ocular symptoms (Bousquet, Khaltaev et al. 2008). It is supported by high 
quality of evidence (Brozek, Bousquet et al. 2010) and meta-analysis (Weiner, Abramson et al. 
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1998) that intranasal glucocorticoids are more effective over oral and topical H1-antihistamines 
(Brozek, Bousquet et al. 2010), and can be used during competition. In a cross-sectional survey 
in 446 athletes, treatment with corticosteroids was associated with significantly improved 
nasal symptoms and quality of life (Alaranta, Alaranta et al. 2005). They have slow onset of 
action (12h) and maximum efficacy over weeks (van Cauwenberge, Bachert et al. 2000). A 
recent review of Laekeman concluded that inhaled corticosteroids require continuous therapy, 
at least for the symptoms duration (Laekeman, Simoens et al. 2010). 
Systemic corticosteroids are indeed the last resort for allergic rhinitis treatment (van 
Cauwenberge, Bachert et al. 2000). They are prohibited by WADA when administered 
orally, rectally or by intravenous or intramuscular administration(WADA 2011). If these 
formulations are indeed necessary for disease treatment, a Therapeutic Use Exemption may 
give that athlete the authorization to take the needed medicine (WADA 2011). 
2.6.3 Allergen immunotherapy 
Allergen vaccines (specific immunotherapy; IT) are very effective in controlling symptoms 
of allergic rhinitis, can potentially modify the disease, and their clinical benefits may be 
sustained years after discontinuing treatment (Wallace, Dykewicz et al. 2008; Brozek, 
Bousquet et al. 2010). It is a valuable option, as stated in the 2010 ARIA guidelines, and 
indicated in symptomatic patients, with proven allergy (demonstrated by IgE antibodies or 
positive skin prick tests), with a significant and unavoidable exposure and whose symptoms 
are not controlled with pharmacological therapy (Wallace, Dykewicz et al. 2008). Athletes 
are frequently included in this group, namely in the case of pollen-allergic athletes who train 
and compete in outdoor environment, and with symptoms that affect their performance 
(Delgado, Moreira et al. 2006). This treatment when performed should be done by trained 
allergist and the athlete warned not to train in a few hours after immunotherapy injection, to 
reduce the risk of systemic reactions. Subcutaneous immunotherapy (SIT) is recommended 
in adults and children with seasonal and persistent allergic rhinitis caused by house dust 
mites (Brozek, Bousquet et al. 2010). In some cases sublingual specific immunotherapy 
(SLIT) can be used, namely in adults with rhinitis caused by pollens or house dust mites and 
in children in pollen-mediated allergy (Scadding, Durham et al. 2008; Brozek, Bousquet et al. 
2010). Other forms of immunotherapy might be introduced, namely intranasal allergen 
specific immunotherapy in adults (Brozek, Bousquet et al. 2010) 
2.6.4 Other potential treatment options 
Other pharmacological treatments can be used in athletes, as a second line approach. 
Antileukotrienes inhibit inflammatory mediators produced in both allergic and nonallergic 
rhinitis, particularly after cold, allergen and exercise challenge (Delgado, Moreira et al. 
2006). Recent guidelines recommend its use in seasonal allergic rhinitis in adults and 
children and only in children in the persistent form of rhinitis (Brozek, Bousquet et al. 2010). 
Disodium cromoglycate and sodium nedocromil are used in allergic rhinitis as intranasal 
and ocular preparations. They are effective in some patients, have excellent safety profile, 
but its use 4 times a day compromises compliance (Scadding, Durham et al. 2008). 
Comparing to antihistamines they seem less effective (Brozek, Bousquet et al. 2010). They 
have a specific role in the prophylactic treatment of allergic conjunctivitis (Bousquet, 
Khaltaev et al. 2008) 
Intranasal ipatropium bromide decreases rhinorrea inhibiting parasympathetic stimulation, 
but does not act in any other rhinitis symptoms (Bousquet, Khaltaev et al. 2008). For this, it 
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has a small role in allergic rhinitis, but may be useful in winter sports (“skiers nose”) 
increasing the ability of the nose to warm and humidify the air, reducing watery 
rhinorrhoea caused by exposure to cold dry air (Katelaris, Carrozzi et al. 2003). 
Topical saline is beneficial in chronic rhinorrhea and rhinosinusitis, when used as sole 
modality or in association with inhaled corticosteroids (Wallace, Dykewicz et al. 2008). 
Anti-IgE (Omalizumab) use in allergic rhinitis is not proved cost-effective (Bousquet, 
Khaltaev et al. 2008). A possible indication for this therapy is in asthmatic patient with 
concomitant allergic rhinitis, with a clear IgE-dependent allergic component, and 
uncontrolled despite treatment (Kopp 2011). 
Other options like homeopathy, acupuncture, herbal medicines and even physical 
techniques have not proven their efficacy (Brozek, Bousquet et al. 2010). 
2.7 Allergic rhinitis as a risk factor for asthma in athletes 
Asthma and allergic rhinitis frequently coexist (Bousquet, Khaltaev et al. 2008). The 
prevalence of asthma in patients with rhinitis varies between 10-40% and rhinitis seems to 
be an independent factor in the risk of asthma (Bonini, Bonini et al. 2006). It is not still clear 
whether allergic rhinitis is an earlier clinical manifestation of allergic disease in atopic 
patients who will develop asthma, or the nasal disease itself is a causative for asthma 
(Bousquet, Khaltaev et al. 2008). A very recent study with a 4 decades follow-up of nearly 
2000 children found that childhood eczema and rhinitis in combination predicted both new-
onset atopic asthma by middle age and the persistence of childhood asthma to adult atopic 
asthma (Martin, Matheson et al. 2011). Ciprandi in several studies evaluated the impact of 
allergic rhinitis in spirometry, bronchodilation and bronchial hyperreactivity results and 
found a persistent association (Ciprandi, Cirillo et al. 2008; Cirillo, Pistorio et al. 2009; 
Ciprandi, Cirillo et al. 2011). 
Allergic rhinitis and asthma have some strong similarities on inflammation mechanisms. An 
eosinophilic type of inflammation is present in both upper and lower airways in rhinitic 
patients. In these patients, nasal allergen challenge can induce increased bronchial 
hyperresponsiveness, which might represent a sign of common inflammatory features 
(Bonini, Bonini et al. 2006). In fact, on nasal and bronchial mucosa a similar inflammatory 
infiltrate is seen, including eosinophils, mast cell, T lymphocytes, and monocytes with 
similar proinflammatory mediators (histamine, CysLT), Th2 cytokines and chemokines 
(Bousquet, Khaltaev et al. 2008). Perhaps the inflammation magnitude in these diseases, 
which represent the systemic response to allergy, may be different resulting in different 
manifestations (Bousquet, Khaltaev et al. 2008). 
The management of allergic rhinitis also improves asthma control and reduces asthma 
severity (Bousquet, Khaltaev et al. 2008). Intranasal steroids seem to prevent seasonal 
increase in nonspecific bronchial hyperreactivity and asthma symptoms associated with 
pollen exposure, and reduce asthma symptoms, exercise-induced bronchospasm and 
bronchial responsiveness to methacoline (Bonini, Bonini et al. 2006). Three post-hoc studies 
described in the ARIA guidelines showed that allergic rhinitis treatment reduced potential 
utilization of healthcare for co-morbid asthma (Bousquet, Khaltaev et al. 2008). 
Elite athletes commonly use drugs to treat asthma, exercise-induced bronchial symptoms 
and rhinitis. They should be adapted accordingly to WADA, and Therapeutic Use 
Exemptions should be made with appropriate diagnostic approach, namely medical history, 
physical examination, spirometry and beta-2 agonist reversibility bronchoconstrition and, if 
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necessary, bronchial provocation test to establish the presence of airway 
hyperresponsiveness. 
Exercise-induced asthma (EAI) also occurs with allergic rhinitis patients, but frequently goes 
undiagnosed in children and athletes, because of normal spirometry and negative history 
(Bonini, Bonini et al. 2006). Every athlete should be screened for asthma or exercise-induced-
asthma, including resting spirometry with bronchodilator response and, if not conclusive, 
bronchial provocation with methacoline or exercise challenge in the usual sports field 
environment or in a controlled environment in the laboratory (Delgado, Moreira et al. 2006). 
3. Conclusion 
Allergic rhinitis is a very common disease that in athletes may negatively impact athletic 
performance. Early recognition, diagnosis and treatment are crucial for improving nasal 
function and reduce the risk of asthma during exercise and competition. This population 
represents a diagnostic challenge for allergic conditions and are submitted to several risk 
factors. So, in order to avoid these risks, all elite athletes should be screened for atopy with 
skin prick tests and/or specific IgE blood tests, and allergic symptoms evaluated using 
validated and adapted questionnaires. Proper and accurate treatment will allow athletes to 
compete at the same level as the non allergic ones. For treatment, inhaled corticosteroids 
represent the first line of treatment in association with second-generation anti-histamines 
accordingly to the severity of symptoms. All athletes with rhinitis should be evaluated for 
asthma and exercise-induced asthma, in accordance to their association and the potential 
risk of allergic rhinitis for asthma. 
4. References 
Alaranta, A., H. Alaranta, et al. (2005). "Allergic rhinitis and pharmacological management 
in elite athletes." Medicine and Science in Sports and Exercise 37(5): 707-711. 
Alves, A., C. Martins, et al. (2010). "Exercise-induced rhinitis in competitive swimmers." Am 
J Rhinol Allergy 24(5): e114-117. 
Bonay, M. and M. Aubier (2007). "Pollution atmosphérique et maladies respiratoires 
allergiques." Med Sci (Paris) 23(2): 187-192. 
Bonini, M., F. Braido, et al. (2009). "AQUA: Allergy Questionnaire for Athletes. 
Development and validation." Med Sci Sports Exerc 41(5): 1034-1041. 
Bonini, S., M. Bonini, et al. (2006). "Rhinitis and asthma in athletes: An ARIA document in 
collaboration with GA2LEN." Allergy: European Journal of Allergy and Clinical 
Immunology 61(6): 681-692. 
Borres, M. P. (2009). "Allergic rhinitis: more than just a stuffy nose." Acta Paediatr 98(7): 
1088-1092. 
Bousquet, J., N. Khaltaev, et al. (2008). "Allergic Rhinitis and its Impact on Asthma (ARIA) 
2008 update (in collaboration with the World Health Organization, GA(2)LEN and 
AllerGen)." Allergy 63 Suppl 86: 8-160. 
Braat, J. P., P. G. Mulder, et al. (1998). "Intranasal cold dry air is superior to histamine 
challenge in determining the presence and degree of nasal hyperreactivity in 
nonallergic noninfectious perennial rhinitis." Am J Respir Crit Care Med 157(6 Pt 
1): 1748-1755. 
www.intechopen.com
 
Allergic Rhinitis 
 
134 
Brozek, J. L., J. Bousquet, et al. (2010). "Allergic Rhinitis and its Impact on Asthma (ARIA) 
guidelines: 2010 revision." J Allergy Clin Immunol 126(3): 466-476. 
Carlsen, K. H., S. D. Anderson, et al. (2008). "Exercise-induced asthma, respiratory and 
allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I 
of the report from the Joint Task Force of the European Respiratory Society (ERS) 
and the European Academy of Allergy and Clinical Immunology (EAACI) in 
cooperation with GA2LEN." Allergy 63(4): 387-403. 
Ciprandi, G., I. Cirillo, et al. (2008). "Impact of allergic rhinitis on asthma: effects on 
spirometric parameters." Allergy 63(3): 255-260. 
Ciprandi, G., I. Cirillo, et al. (2011). "Impact of allergic rhinitis on bronchi: An 8-year follow-
up study." Am J Rhinol Allergy 25(2): 72-76. 
Cirillo, I., A. Pistorio, et al. (2009). "Impact of allergic rhinitis on asthma: effects on bronchial 
hyperreactivity." Allergy 64(3): 439-444. 
D'Amato, G. and L. Cecchi (2008). "Effects of climate change on environmental factors in 
respiratory allergic diseases." Clin Exp Allergy 38(8): 1264-1274. 
Dahl, R. and N. Mygind (1998). "Mechanisms of airflow limitation in the nose and lungs." 
Clin Exp Allergy 28 Suppl 2: 17-25. 
Davila, I., J. Mullol, et al. (2009). "Genetic aspects of allergic rhinitis." J Investig Allergol Clin 
Immunol 19 Suppl 1: 25-31. 
Delgado, L., A. Moreira, et al. (2006). "Rhinitis and its impact on sports." Allergy and 
Clinical Immunology International 18(3): 98-105. 
Dijkstra, H. P. and P. Robson-Ansley (2011). "The prevalence and current opinion of 
treatment of allergic rhinitis in elite athletes." Current Opinion in Allergy and 
Clinical Immunology(11): 103–108. 
Durham, S. R. (1998). "Mechanisms of mucosal inflammation in the nose and lungs." Clin 
Exp Allergy 28 Suppl 2: 11-16. 
Dykewicz, M. S. and D. L. Hamilos (2010). "Rhinitis and sinusitis." Journal of Allergy and 
Clinical Immunology 125(2 SUPPL. 2): S103-S115. 
Ferrer, M., M. Morais-Almeida, et al. (2010). "Evaluation of treatment satisfaction in children 
with allergic disease treated with an antihistamine: an international, non-
interventional, retrospective study." Clin Drug Investig 30(1): 15-34. 
Fonseca, J. A., L. Nogueira-Silva, et al. (2010). "Validation of a questionnaire (CARAT10) to 
assess rhinitis and asthma in patients with asthma." Allergy 65(8): 1042-1048. 
Gioulekas, D., A. Damialis, et al. (2003). "15-year aeroallergen records. Their usefulness in 
Athens Olympics, 2004." Allergy 58(9): 933-938. 
Helbling, A., P. Jenoure, et al. (1990). "[The incidence of hay fever in leading Swiss athletes]." 
Schweiz Med Wochenschr 120(7): 231-236. 
Helenius, I. and T. Haahtela (2000). "Allergy and asthma in elite summer sport athletes." J 
Allergy Clin Immunol 106(3): 444-452. 
Kaelin, M. and O. Brandli (1993). "[Exertional asthma in Swiss top-ranking athletes]." 
Schweiz Med Wochenschr 123(5): 174-182. 
Katelaris, C. H., F. M. Carrozzi, et al. (2003). "Allergic rhinoconjunctivitis in elite athletes: 
Optimal management for quality of life and performance." Sports Medicine 33(6): 
401-406. 
www.intechopen.com
 
Allergic Rhinitis and Sports 
 
135 
Katelaris, C. H., F. M. Carrozzi, et al. (2000). "A springtime Olympics demands special 
consideration for allergic athletes." Journal of Allergy and Clinical Immunology 
106(2): 260-266. 
Katelaris, C. H., F. M. Carrozzi, et al. (2002). "Effects of intranasal budesonide on symptoms, 
quality of life, and performance in elite athletes with allergic rhinoconjunctivitis." 
Clinical Journal of Sport Medicine 12(5): 296-300. 
Katelaris, C. H., F. M. Carrozzi, et al. (2006). "Patterns of allergic reactivity and disease in 
Olympic athletes." Clin J Sport Med 16(5): 401-405. 
Komarow, H. D. and T. T. Postolache (2005). "Seasonal allergy and seasonal decrements in 
athletic performance." Clinics in Sports Medicine 24(2): e35-e50. 
Kopp, M. V. (2011). "Omalizumab: Anti-IgE therapy in allergy." Curr Allergy Asthma Rep 
11(2): 101-106. 
Koskela, H. O. (2007). "Cold air-provoked respiratory symptoms: the mechanisms and 
management." Int J Circumpolar Health 66(2): 91-100. 
Laekeman, G., S. Simoens, et al. (2010). "Continuous versus on-demand pharmacotherapy of 
allergic rhinitis: evidence and practice." Respir Med 104(5): 615-625. 
Langdeau, J. B., H. Turcotte, et al. (2004). "Comparative prevalence of asthma in different 
groups of athletes: a survey." Can Respir J 11(6): 402-406. 
Li, J., Y. Lu, et al. (2008). "Chinese response to allergy and asthma in olympic athletes." 
Allergy: European Journal of Allergy and Clinical Immunology 63(8): 962-968. 
Lim, M. Y. and J. L. Leong (2010). "Allergic rhinitis: evidence-based practice." Singapore 
Med J 51(7): 542-550. 
Lubitz, S., W. Schober, et al. (2010). "Polycyclic aromatic hydrocarbons from diesel emissions 
exert proallergic effects in birch pollen allergic individuals through enhanced 
mediator release from basophils." Environ Toxicol 25(2): 188-197. 
Martin, P. E., M. C. Matheson, et al. (2011). "Childhood eczema and rhinitis predict atopic 
but not nonatopic adult asthma: A prospective cohort study over 4 decades." J 
Allergy Clin Immunol 127(6): 1473-1479 e1471. 
Moreira, A., R. Kekkonen, et al. (2007). "Allergy in marathon runners and effect of 
Lactobacillus GG supplementation on allergic inflammatory markers." Respir Med 
101(6): 1123-1131. 
Moreira, A. D., L. ; Moreira, P. ; Haahtela, T. (2009). "Does exercise increase the risk of upper 
respiratory tract infections?" British Medical Bulletin(90): 111-131. 
Scadding, G., P. Hellings, et al. (2011). "Diagnostic Tools In Rhinology EAACI position 
paper." Clinical and Translational Allergy 1(1): 2. 
Scadding, G. K., S. R. Durham, et al. (2008). "BSACI guidelines for the management of 
allergic and non-allergic rhinitis." Clin Exp Allergy 38(1): 19-42. 
Schatz, M., E. O. Meltzer, et al. (2010). "Psychometric validation of the rhinitis control 
assessment test: a brief patient-completed instrument for evaluating rhinitis 
symptom control." Ann Allergy Asthma Immunol 104(2): 118-124. 
Schwartz, L. B., L. Delgado, et al. (2008). "Exercise-induced hypersensitivity syndromes in 
recreational and competitive athletes: a PRACTALL consensus report (what the 
general practitioner should know about sports and allergy)." Allergy 63(8): 953-961. 
Shusterman, D., J. Balmes, et al. (2003). "Chlorine inhalation produces nasal congestion in 
allergic rhinitics without mast cell degranulation." Eur Respir J 21(4): 652-657. 
www.intechopen.com
 
Allergic Rhinitis 
 
136 
Shusterman, D., M. A. Murphy, et al. (2003). "Influence of age, gender, and allergy status on 
nasal reactivity to inhaled chlorine." Inhal Toxicol 15(12): 1179-1189. 
Shusterman, D. J., M. A. Murphy, et al. (1998). "Subjects with seasonal allergic rhinitis and 
nonrhinitic subjects react differentially to nasal provocation with chlorine gas." J 
Allergy Clin Immunol 101(6 Pt 1): 732-740. 
Thomas, S., B. Wolfarth, et al. (2010). "Self-reported asthma and allergies in top athletes 
compared to the general population - results of the German part of the GA2LEN-
Olympic study 2008." Allergy Asthma Clin Immunol 6(1): 31. 
Valero, A., C. Serrano, et al. (2005). "Nasal and bronchial response to exercise in patients 
with asthma and rhinitis: the role of nitric oxide." Allergy 60(9): 1126-1131. 
van Cauwenberge, P., C. Bachert, et al. (2000). "Consensus statement on the treatment of 
allergic rhinitis. European Academy of Allergology and Clinical Immunology." 
Allergy 55(2): 116-134. 
WADA (2011). "World Anti-Doping Code- The 2011 prohibited list international standard." 
Wallace, D. V., M. S. Dykewicz, et al. (2008). "The diagnosis and management of rhinitis: An 
updated practice parameter." Journal of Allergy and Clinical Immunology 122(2, 
Supplement 1): S1-S84. 
Walsh, N. P., M. Gleeson, et al. (2011). "Position statement. Part one: Immune function and 
exercise." Exerc Immunol Rev 17: 6-63. 
Weiner, J. M., M. J. Abramson, et al. (1998). "Intranasal corticosteroids versus oral H1 
receptor antagonists in allergic rhinitis: systematic review of randomised controlled 
trials." BMJ 317(7173): 1624-1629. 
Zhang, F., W. Wang, et al. (2011). "Time-series studies on air pollution and daily outpatient 
visits for allergic rhinitis in Beijing, China." Science of The Total Environment 
409(13): 2486-2492. 
www.intechopen.com
Allergic Rhinitis
Edited by Prof. Marek Kowalski
ISBN 978-953-51-0288-5
Hard cover, 214 pages
Publisher InTech
Published online 21, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Allergic rhinitis, while troublesome for a patient, may be also a challenge for the physician. That is why
physicians must still learn more on the pathophysiology, clinical spectrum and novel diagnostic and therapeutic
approaches to the disease. The chapters of this volume address a variety of important topics related to allergic
rhinitis. They begin with a description of innovative translational approaches allowing for unification of animal
and human models. Contributing authors provide up-to-date reviews of clinical aspects of allergic rhinitis in
children, its association with bronchial asthma and other co-morbid conditions. They also discuss the impact of
allergic rhinitis on sleep and sports. Together with articles on diagnostic approaches as well as novel
treatments, the book offers a comprehensive and stimulating review of the topic. May this book find a wide
readership among allergists and other physicians interested in allergic disease, and also among pediatricians,
general practitioners and other specialists who increasingly have to deal with this seemingly benign, but
sometimes extremely troublesome, disease.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Silva Diana, Moreira André and Delgado Luís (2012). Allergic Rhinitis and Sports, Allergic Rhinitis, Prof. Marek
Kowalski (Ed.), ISBN: 978-953-51-0288-5, InTech, Available from: http://www.intechopen.com/books/allergic-
rhinitis/allergic-rhinitis-and-sports
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
